1. Home
  2. DOMH vs TENX Comparison

DOMH vs TENX Comparison

Compare DOMH & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dominari Holdings Inc.

DOMH

Dominari Holdings Inc.

HOLD

Current Price

$3.64

Market Cap

47.2M

Sector

Health Care

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$11.75

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMH
TENX
Founded
1967
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
56.2M
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
DOMH
TENX
Price
$3.64
$11.75
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
85.7K
605.5K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
23.45%
N/A
EPS Growth
34.03
N/A
EPS
N/A
N/A
Revenue
$123,104,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
578.41
N/A
52 Week Low
$2.69
$5.34
52 Week High
$8.40
$18.38

Technical Indicators

Market Signals
Indicator
DOMH
TENX
Relative Strength Index (RSI) 68.30 37.17
Support Level $2.75 $10.83
Resistance Level $5.09 $14.15
Average True Range (ATR) 0.19 0.95
MACD 0.08 -0.28
Stochastic Oscillator 95.79 7.00

Price Performance

Historical Comparison
DOMH
TENX

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: